董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Jing Cao | 男 | Chief Executive Officer and Director | 44 | 未披露 | 未持股 | 2022-04-25 |
| Qiang Wang | 男 | Director | 45 | 未披露 | 未持股 | 2022-04-25 |
| Xin Wang | 男 | Independent Director | 48 | 未披露 | 未持股 | 2022-04-25 |
| Joshua Gordon | 男 | Independent Director | 49 | 未披露 | 未持股 | 2022-04-25 |
| James J. Long | 男 | Independent Director | 51 | 未披露 | 未持股 | 2022-04-25 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Jing Cao | 男 | Chief Executive Officer and Director | 44 | 未披露 | 未持股 | 2022-04-25 |
| Nicholas Torres III | 男 | Chief Financial Officer | 40 | 未披露 | 未持股 | 2022-04-25 |
董事简历
中英对照 | 中文 | 英文- Jing Cao
-
我们的首席执行官兼董事Jing Cao是一位经验丰富的技术和金融行业专业人士。曹先生于2018年5月创立并担任Ascendex的首席执行官，Ascendex是一家为全球用户提供各种产品的全球数字资产交易平台。自2018年3月起，他还担任纽约技术咨询服务公司HD Consulting Service LLC、交易平台技术控股公司BMXDM Technology Pte. Limited和Global Digital Mercantile Holdings Limited的首席执行官。在担任这些职位之前，曹先生于2013年1月至2018年1月创立并担任Delpha Capital Management，LLC & # 8220；Delpha Capital & # 8221；的首席投资官，这是一家总部位于纽约的专门从事量化交易的公司。在加入Delpha Capital之前，曹先生于2010年8月至2012年11月担任Barclays Capital（8220；Barclays & 8221；）纽约和伦敦办事处股票部门的高级投资组合经理。2008年8月至2010年7月，曹先生在Knight Capital Group担任投资组合经理，研究和交易美国股票。曹获得了博士学位。芝加哥大学计算机科学学士学位和中国科学技术大学计算机科学与工程学士学位。
Jing Cao,our Chief Executive Officer and director, is an experienced technology and finance industry professional. In May 2018 Mr. Cao founded and has since served as the Chief Executive Office of AscendEX, a global digital asset trading platform that offers a variety of products to global users. Since March 2018 he also served as the Chief Executive Officer of HD Consulting Service LLC, a technology consulting service firm in New York, BMXDM Technology PTE. Limited, a technology holdings company for a trading platform, and Global Digital Mercantile Holdings Limited. Prior to these positions, from January 2013 to January 2018 Mr. Cao founded and served as the Chief Investment Officer of Delpha Capital Management, LLC “Delpha Capital”, a New York based firm that specialized in quantitative trading. Prior to Delpha Capital, from August 2010 to November 2012 Mr. Cao was a senior Portfolio Manager in the Equity Division of Barclays Capital (“Barclays”) in both their New York and London offices. From August 2008 to July 2010 Mr. Cao was a Portfolio Manager at Knight Capital Group where he researched and traded U.S. equities.Mr. Cao earned a Ph.D. in Computer Science from the University of Chicago and a bachelor's degree in Computer Science and Engineering from the University of Science and Technology of China. - 我们的首席执行官兼董事Jing Cao是一位经验丰富的技术和金融行业专业人士。曹先生于2018年5月创立并担任Ascendex的首席执行官，Ascendex是一家为全球用户提供各种产品的全球数字资产交易平台。自2018年3月起，他还担任纽约技术咨询服务公司HD Consulting Service LLC、交易平台技术控股公司BMXDM Technology Pte. Limited和Global Digital Mercantile Holdings Limited的首席执行官。在担任这些职位之前，曹先生于2013年1月至2018年1月创立并担任Delpha Capital Management，LLC & # 8220；Delpha Capital & # 8221；的首席投资官，这是一家总部位于纽约的专门从事量化交易的公司。在加入Delpha Capital之前，曹先生于2010年8月至2012年11月担任Barclays Capital（8220；Barclays & 8221；）纽约和伦敦办事处股票部门的高级投资组合经理。2008年8月至2010年7月，曹先生在Knight Capital Group担任投资组合经理，研究和交易美国股票。曹获得了博士学位。芝加哥大学计算机科学学士学位和中国科学技术大学计算机科学与工程学士学位。
- Jing Cao,our Chief Executive Officer and director, is an experienced technology and finance industry professional. In May 2018 Mr. Cao founded and has since served as the Chief Executive Office of AscendEX, a global digital asset trading platform that offers a variety of products to global users. Since March 2018 he also served as the Chief Executive Officer of HD Consulting Service LLC, a technology consulting service firm in New York, BMXDM Technology PTE. Limited, a technology holdings company for a trading platform, and Global Digital Mercantile Holdings Limited. Prior to these positions, from January 2013 to January 2018 Mr. Cao founded and served as the Chief Investment Officer of Delpha Capital Management, LLC “Delpha Capital”, a New York based firm that specialized in quantitative trading. Prior to Delpha Capital, from August 2010 to November 2012 Mr. Cao was a senior Portfolio Manager in the Equity Division of Barclays Capital (“Barclays”) in both their New York and London offices. From August 2008 to July 2010 Mr. Cao was a Portfolio Manager at Knight Capital Group where he researched and traded U.S. equities.Mr. Cao earned a Ph.D. in Computer Science from the University of Chicago and a bachelor's degree in Computer Science and Engineering from the University of Science and Technology of China.
- Qiang Wang
-
王强，担任董事。王先生是一位经验丰富的银行和资产管理专业人士。自2020年2月起，王先生担任中国银行集团投资有限公司在美国的全资子公司7BP Owner，LLC的总经理，主要负责收购公司股权、资产收购、以及一线城市和核心区域的写字楼、商业综合体等成熟的商业地产项目。作为总经理，王先生管理和参与公司在美国的房地产资产投资的各个方面，并提供跨资本结构和风险范围的综合融资解决方案。在此之前，王先生于2011年10月至2020年2月担任纽约中国银行美国分行的副总裁和高级经理，其主要职责涉及企业银行和金融机构。王先生在道林学院获得工商管理学士学位，在山东师范大学获得音乐管理学士学位。
Qiang Wang,serves as a director. Mr. Wang is an experienced banking and asset management professional. Since February 2020 Mr. Wang has served as the general manager of 7BP Owner, LLC, a wholly owned subsidiary of Bank of China Group Investment Limited in the US, with main emphasis on acquisition of company equity, asset acquisition, and mature commercial real estate projects such as office buildings and commercial mix used buildings in first-tier cities and core areas. As the General Manager, Mr. Wang manages and participates in all aspects of the company's real estate asset investment in the US, and provides comprehensive financing solutions across the capital structure and risk spectrum. Prior to this role, from October 2011 to February 2020 Mr. Wang served as a vice president and a senior manager of the Bank of China USA in New York where his main responsibilities pertained to corporate banking and financial institutions.Mr. Wang earned a bachelor's degree in Business Administration from Dowling College, and a bachelor's degree in Music Management from Shandong Normal University. - 王强，担任董事。王先生是一位经验丰富的银行和资产管理专业人士。自2020年2月起，王先生担任中国银行集团投资有限公司在美国的全资子公司7BP Owner，LLC的总经理，主要负责收购公司股权、资产收购、以及一线城市和核心区域的写字楼、商业综合体等成熟的商业地产项目。作为总经理，王先生管理和参与公司在美国的房地产资产投资的各个方面，并提供跨资本结构和风险范围的综合融资解决方案。在此之前，王先生于2011年10月至2020年2月担任纽约中国银行美国分行的副总裁和高级经理，其主要职责涉及企业银行和金融机构。王先生在道林学院获得工商管理学士学位，在山东师范大学获得音乐管理学士学位。
- Qiang Wang,serves as a director. Mr. Wang is an experienced banking and asset management professional. Since February 2020 Mr. Wang has served as the general manager of 7BP Owner, LLC, a wholly owned subsidiary of Bank of China Group Investment Limited in the US, with main emphasis on acquisition of company equity, asset acquisition, and mature commercial real estate projects such as office buildings and commercial mix used buildings in first-tier cities and core areas. As the General Manager, Mr. Wang manages and participates in all aspects of the company's real estate asset investment in the US, and provides comprehensive financing solutions across the capital structure and risk spectrum. Prior to this role, from October 2011 to February 2020 Mr. Wang served as a vice president and a senior manager of the Bank of China USA in New York where his main responsibilities pertained to corporate banking and financial institutions.Mr. Wang earned a bachelor's degree in Business Administration from Dowling College, and a bachelor's degree in Music Management from Shandong Normal University.
- Xin Wang
-
Xin Wang，独立董事。自2020年3月起，王先生担任Genesis MedTech Corporation的董事长兼首席执行官，Genesis MedTech Corporation总部位于新加坡。Genesis是中国一个完全整合的医疗技术平台，其活动范围从副总裁和创新、制造到分销，在成立Genesis之前，2012年6月至2020年3月，王先生担任波士顿科学公司亚太区高级总裁兼总裁，及其执行委员会成员。在波士顿科学公司的8年里，王先生为可持续的业务扩张奠定了坚实的基础，并建立了一支强大、多元化和高绩效的团队，在亚太地区实现了强劲的增长。在加入波士顿科学公司之前，他在副总裁工作了11年，先后在美国担任高级职务，最终被任命为中国医疗器械业务副总裁。王先生的职业生涯始于英国石油公司。王先生在医疗技术行业担任高级管理人员和业务发展策略师超过二十年，在发展新业务合作方面拥有丰富的专业知识。他热衷于倡导可以对患者生活产生可衡量影响的有意义的创新。在整个职业生涯中，王先生一直专注于推动医疗技术行业的变革，同时为业务合作伙伴提供产生影响的机会。Wang拥有芝加哥大学布斯商学院市场营销和金融MBA学位，以及北京对外经济贸易大学经济学学士学位。
Xin Wang,serves as an independent director. Since March 2020 Mr. Wang is Chairman and Chief Executive Officer of Genesis Medtech Corporation “Genesis”, headquartered in Singapore. Genesis is a fully integrated medtech platform in China, with activities ranging from product development and innovation, manufacturing to distribution.Prior to setting up Genesis, from June 2012 to March 2020 Mr. Wang was Senior Vice President and President, for Asia Pacific, for Boston Scientific, and a member of its Executive Committee. Throughout his 8 years in Boston Scientific, Mr. Wang laid a strong foundation for sustainable business expansion and built a strong, diversified and high performing team that achieved strong growth in Asia Pacific region. Prior to Boston Scientific, he was with Johnson & Johnson for 11 years where he held successively senior roles based in the US, culminating in his appointment as vice president of the medical device business in China. Mr. Wang started his career with British Petroleum.With more than two decades of experience as a senior executive and business development strategist in the med-tech industry, Mr. Wang has a wealth of expertise in developing new business collaborations. He is passionate about championing meaningful innovations that can have a measurable impact on patients' lives. Throughout his career, Mr. Wang has focused on driving change in the med-tech industry, whilst providing business partners with opportunities to make an impact.Mr. Wang earned an MBA in Marketing and Finance from the University of Chicago, Booth School of Business, and a bachelor's degree in Economics from the University of International Business and Economics in Beijing. - Xin Wang，独立董事。自2020年3月起，王先生担任Genesis MedTech Corporation的董事长兼首席执行官，Genesis MedTech Corporation总部位于新加坡。Genesis是中国一个完全整合的医疗技术平台，其活动范围从副总裁和创新、制造到分销，在成立Genesis之前，2012年6月至2020年3月，王先生担任波士顿科学公司亚太区高级总裁兼总裁，及其执行委员会成员。在波士顿科学公司的8年里，王先生为可持续的业务扩张奠定了坚实的基础，并建立了一支强大、多元化和高绩效的团队，在亚太地区实现了强劲的增长。在加入波士顿科学公司之前，他在副总裁工作了11年，先后在美国担任高级职务，最终被任命为中国医疗器械业务副总裁。王先生的职业生涯始于英国石油公司。王先生在医疗技术行业担任高级管理人员和业务发展策略师超过二十年，在发展新业务合作方面拥有丰富的专业知识。他热衷于倡导可以对患者生活产生可衡量影响的有意义的创新。在整个职业生涯中，王先生一直专注于推动医疗技术行业的变革，同时为业务合作伙伴提供产生影响的机会。Wang拥有芝加哥大学布斯商学院市场营销和金融MBA学位，以及北京对外经济贸易大学经济学学士学位。
- Xin Wang,serves as an independent director. Since March 2020 Mr. Wang is Chairman and Chief Executive Officer of Genesis Medtech Corporation “Genesis”, headquartered in Singapore. Genesis is a fully integrated medtech platform in China, with activities ranging from product development and innovation, manufacturing to distribution.Prior to setting up Genesis, from June 2012 to March 2020 Mr. Wang was Senior Vice President and President, for Asia Pacific, for Boston Scientific, and a member of its Executive Committee. Throughout his 8 years in Boston Scientific, Mr. Wang laid a strong foundation for sustainable business expansion and built a strong, diversified and high performing team that achieved strong growth in Asia Pacific region. Prior to Boston Scientific, he was with Johnson & Johnson for 11 years where he held successively senior roles based in the US, culminating in his appointment as vice president of the medical device business in China. Mr. Wang started his career with British Petroleum.With more than two decades of experience as a senior executive and business development strategist in the med-tech industry, Mr. Wang has a wealth of expertise in developing new business collaborations. He is passionate about championing meaningful innovations that can have a measurable impact on patients' lives. Throughout his career, Mr. Wang has focused on driving change in the med-tech industry, whilst providing business partners with opportunities to make an impact.Mr. Wang earned an MBA in Marketing and Finance from the University of Chicago, Booth School of Business, and a bachelor's degree in Economics from the University of International Business and Economics in Beijing.
- Joshua Gordon
-
Joshua Gordon，担任独立董事。自2018年以来，Gordon先生一直担任电信服务提供商Karma Mobility LLC的管理成员。2005年，Gordon先生创立并一直担任移动虚拟网络运营商MVNO业务Red Pocket，Inc.的首席执行官。在加入Red Pocket，Inc.之前，Gordon先生于2005年共同创立并一直担任民主委员会董事会成员，民主委员会是一家总部位于洛杉矶的非营利、无党派组织，致力于加强各地的民主机构世界。2021年，Gordon先生是阿斯彭研究所的技术执行领导倡议研究员。他之前曾在美国铁塔公司（纽约证券交易所代码：AMT）、Interpacket Networks和Justice Telecom的Verestar，Inc.担任过高管职位，并且是夏威夷檀香山东西中心的学位研究员。Gordon拥有哈佛法学院的法学博士学位、夏威夷大学马诺阿分校的东南亚研究文学硕士学位和威廉姆斯学院的学士学位。
Joshua Gordon,serves as an independent director. Since 2018 Mr. Gordon has been serving as a managing member for Karma Mobility LLC, a telecommunications service provider. In 2005 Mr. Gordon founded and has been serving as the Chief Executive Officer of Red Pocket, Inc., a Mobile Virtual Network Operator MVNO business. Prior to Red Pocket, Inc., in 2005 Mr. Gordon co-founded and has been serving as a Member of the Board of the Democracy Council, a Los Angeles-based non-profit, non-partisan organization dedicated to strengthening democratic institutions around the world. In 2021 Mr. Gordon was a Tech Executive Leadership Initiative (TELI) Fellow at the Aspen Institute. He previously held executive positions at Verestar, Inc., an American Tower company (NYSE: AMT), Interpacket Networks, and Justice Telecom, and he was a Degree Fellow at the East-West Center in Honolulu, Hawaii.Mr. Gordon holds a Juris Doctor from Harvard Law School, a Master of Arts in Southeast Asian Studies from the University of Hawaii-Manoa, and a bachelor's degree from Williams College. - Joshua Gordon，担任独立董事。自2018年以来，Gordon先生一直担任电信服务提供商Karma Mobility LLC的管理成员。2005年，Gordon先生创立并一直担任移动虚拟网络运营商MVNO业务Red Pocket，Inc.的首席执行官。在加入Red Pocket，Inc.之前，Gordon先生于2005年共同创立并一直担任民主委员会董事会成员，民主委员会是一家总部位于洛杉矶的非营利、无党派组织，致力于加强各地的民主机构世界。2021年，Gordon先生是阿斯彭研究所的技术执行领导倡议研究员。他之前曾在美国铁塔公司（纽约证券交易所代码：AMT）、Interpacket Networks和Justice Telecom的Verestar，Inc.担任过高管职位，并且是夏威夷檀香山东西中心的学位研究员。Gordon拥有哈佛法学院的法学博士学位、夏威夷大学马诺阿分校的东南亚研究文学硕士学位和威廉姆斯学院的学士学位。
- Joshua Gordon,serves as an independent director. Since 2018 Mr. Gordon has been serving as a managing member for Karma Mobility LLC, a telecommunications service provider. In 2005 Mr. Gordon founded and has been serving as the Chief Executive Officer of Red Pocket, Inc., a Mobile Virtual Network Operator MVNO business. Prior to Red Pocket, Inc., in 2005 Mr. Gordon co-founded and has been serving as a Member of the Board of the Democracy Council, a Los Angeles-based non-profit, non-partisan organization dedicated to strengthening democratic institutions around the world. In 2021 Mr. Gordon was a Tech Executive Leadership Initiative (TELI) Fellow at the Aspen Institute. He previously held executive positions at Verestar, Inc., an American Tower company (NYSE: AMT), Interpacket Networks, and Justice Telecom, and he was a Degree Fellow at the East-West Center in Honolulu, Hawaii.Mr. Gordon holds a Juris Doctor from Harvard Law School, a Master of Arts in Southeast Asian Studies from the University of Hawaii-Manoa, and a bachelor's degree from Williams College.
- James J. Long
-
James J. Long，担任独立董事。自2005年以来，Long先生一直担任Mdland International Corp.的医疗保健部门，Mdland International Corp.是一家总部位于纽约市的数字公司，自2005年10月以来为医疗实践和医疗保健组织提供基于云的技术解决方案。从1998年到2005年，Long先生担任副总裁0的副总裁/顾问，负责财务服务解决方案应用程序的开发和支持。从1995年到1997年，Long先生是Periphonic Corp.（被Nortel Networks Inc.收购）的系统工程师，负责开发第一代基于自然语言处理的语音应用程序，并且是联邦基金小型医疗系统的首席工程师。商业创新研究（& # 8220；SBIR & # 8221；）项目。Long拥有威斯康星大学数字信号处理专业物理学硕士学位和中山大学微型计算机专业物理学学士学位。
James J. Long,serves as an independent director. Since 2005 Mr. Long has been serving as the Chairman and Chief Executive Officer of MDLand International Corp. “MDLand”, a digital healthcare company based in New York City providing cloud-based technology solutions to medical practices and healthcare organizations since October 2005. From 1998 to 2005 Mr. Long was a Vice President/Consultant at JPMorgan Chase, responsible for the development and the support of applications for treasury services solutions. From 1995 to 1997 Mr. Long was a system engineer at Periphonic Corp. (acquired by Nortel Networks Inc.) to develop the first-generation natural language processing-based voice applications and was a principal engineer at Medical Systems for the federally-fund small business innovation research (“SBIR”) project.Mr. Long holds a Master of Science degree in Physics with a concentration in digital signal processing from the University of Wisconsin and a bachelor's degree in Physics with a concentration in microcomputer from Sun Yat-Sen University. - James J. Long，担任独立董事。自2005年以来，Long先生一直担任Mdland International Corp.的医疗保健部门，Mdland International Corp.是一家总部位于纽约市的数字公司，自2005年10月以来为医疗实践和医疗保健组织提供基于云的技术解决方案。从1998年到2005年，Long先生担任副总裁0的副总裁/顾问，负责财务服务解决方案应用程序的开发和支持。从1995年到1997年，Long先生是Periphonic Corp.（被Nortel Networks Inc.收购）的系统工程师，负责开发第一代基于自然语言处理的语音应用程序，并且是联邦基金小型医疗系统的首席工程师。商业创新研究（& # 8220；SBIR & # 8221；）项目。Long拥有威斯康星大学数字信号处理专业物理学硕士学位和中山大学微型计算机专业物理学学士学位。
- James J. Long,serves as an independent director. Since 2005 Mr. Long has been serving as the Chairman and Chief Executive Officer of MDLand International Corp. “MDLand”, a digital healthcare company based in New York City providing cloud-based technology solutions to medical practices and healthcare organizations since October 2005. From 1998 to 2005 Mr. Long was a Vice President/Consultant at JPMorgan Chase, responsible for the development and the support of applications for treasury services solutions. From 1995 to 1997 Mr. Long was a system engineer at Periphonic Corp. (acquired by Nortel Networks Inc.) to develop the first-generation natural language processing-based voice applications and was a principal engineer at Medical Systems for the federally-fund small business innovation research (“SBIR”) project.Mr. Long holds a Master of Science degree in Physics with a concentration in digital signal processing from the University of Wisconsin and a bachelor's degree in Physics with a concentration in microcomputer from Sun Yat-Sen University.
高管简历
中英对照 | 中文 | 英文- Jing Cao
我们的首席执行官兼董事Jing Cao是一位经验丰富的技术和金融行业专业人士。曹先生于2018年5月创立并担任Ascendex的首席执行官，Ascendex是一家为全球用户提供各种产品的全球数字资产交易平台。自2018年3月起，他还担任纽约技术咨询服务公司HD Consulting Service LLC、交易平台技术控股公司BMXDM Technology Pte. Limited和Global Digital Mercantile Holdings Limited的首席执行官。在担任这些职位之前，曹先生于2013年1月至2018年1月创立并担任Delpha Capital Management，LLC & # 8220；Delpha Capital & # 8221；的首席投资官，这是一家总部位于纽约的专门从事量化交易的公司。在加入Delpha Capital之前，曹先生于2010年8月至2012年11月担任Barclays Capital（8220；Barclays & 8221；）纽约和伦敦办事处股票部门的高级投资组合经理。2008年8月至2010年7月，曹先生在Knight Capital Group担任投资组合经理，研究和交易美国股票。曹获得了博士学位。芝加哥大学计算机科学学士学位和中国科学技术大学计算机科学与工程学士学位。
Jing Cao,our Chief Executive Officer and director, is an experienced technology and finance industry professional. In May 2018 Mr. Cao founded and has since served as the Chief Executive Office of AscendEX, a global digital asset trading platform that offers a variety of products to global users. Since March 2018 he also served as the Chief Executive Officer of HD Consulting Service LLC, a technology consulting service firm in New York, BMXDM Technology PTE. Limited, a technology holdings company for a trading platform, and Global Digital Mercantile Holdings Limited. Prior to these positions, from January 2013 to January 2018 Mr. Cao founded and served as the Chief Investment Officer of Delpha Capital Management, LLC “Delpha Capital”, a New York based firm that specialized in quantitative trading. Prior to Delpha Capital, from August 2010 to November 2012 Mr. Cao was a senior Portfolio Manager in the Equity Division of Barclays Capital (“Barclays”) in both their New York and London offices. From August 2008 to July 2010 Mr. Cao was a Portfolio Manager at Knight Capital Group where he researched and traded U.S. equities.Mr. Cao earned a Ph.D. in Computer Science from the University of Chicago and a bachelor's degree in Computer Science and Engineering from the University of Science and Technology of China.- 我们的首席执行官兼董事Jing Cao是一位经验丰富的技术和金融行业专业人士。曹先生于2018年5月创立并担任Ascendex的首席执行官，Ascendex是一家为全球用户提供各种产品的全球数字资产交易平台。自2018年3月起，他还担任纽约技术咨询服务公司HD Consulting Service LLC、交易平台技术控股公司BMXDM Technology Pte. Limited和Global Digital Mercantile Holdings Limited的首席执行官。在担任这些职位之前，曹先生于2013年1月至2018年1月创立并担任Delpha Capital Management，LLC & # 8220；Delpha Capital & # 8221；的首席投资官，这是一家总部位于纽约的专门从事量化交易的公司。在加入Delpha Capital之前，曹先生于2010年8月至2012年11月担任Barclays Capital（8220；Barclays & 8221；）纽约和伦敦办事处股票部门的高级投资组合经理。2008年8月至2010年7月，曹先生在Knight Capital Group担任投资组合经理，研究和交易美国股票。曹获得了博士学位。芝加哥大学计算机科学学士学位和中国科学技术大学计算机科学与工程学士学位。
- Jing Cao,our Chief Executive Officer and director, is an experienced technology and finance industry professional. In May 2018 Mr. Cao founded and has since served as the Chief Executive Office of AscendEX, a global digital asset trading platform that offers a variety of products to global users. Since March 2018 he also served as the Chief Executive Officer of HD Consulting Service LLC, a technology consulting service firm in New York, BMXDM Technology PTE. Limited, a technology holdings company for a trading platform, and Global Digital Mercantile Holdings Limited. Prior to these positions, from January 2013 to January 2018 Mr. Cao founded and served as the Chief Investment Officer of Delpha Capital Management, LLC “Delpha Capital”, a New York based firm that specialized in quantitative trading. Prior to Delpha Capital, from August 2010 to November 2012 Mr. Cao was a senior Portfolio Manager in the Equity Division of Barclays Capital (“Barclays”) in both their New York and London offices. From August 2008 to July 2010 Mr. Cao was a Portfolio Manager at Knight Capital Group where he researched and traded U.S. equities.Mr. Cao earned a Ph.D. in Computer Science from the University of Chicago and a bachelor's degree in Computer Science and Engineering from the University of Science and Technology of China.
- Nicholas Torres III
我们的首席财务官 Nicholas Torres III在金融和资本市场相关职位拥有超过15年的工作经验。自2021年12月以来，Torres先生一直担任Ascendex的高级财务总监，Ascendex是一家为全球用户提供各种产品的全球数字资产交易平台。2016年5月至2021年12月，他担任Bloomberg LP首席财务官服务部的财务总监。2012年11月至2016年4月，Torres先生担任高盛私募股权和企业会计部门的助理。2011年4月至2012年10月，他在脚手架和工业服务公司Safway Atlantic担任公司会计和财务报告助理总监。在加入Safway Atlantic之前，Torres先生于2007年6月至2011年4月担任普华永道的金融分析师。Torres先生拥有雪城大学的经济学学士学位。
Nicholas Torres III,our Chief Financial Officer, has over 15 years of experience working in finance and capital markets-related roles. Since December 2021 Mr. Torres has been serving as the Senior Financial Controller for AscendEX, a global digital asset trading platform that offers a variety of products to global users. From May 2016 to December 2021 he served as a Controller in the Finance Division of CFO Services at Bloomberg LP. From November 2012 to April 2016 Mr. Torres served as an Associate for the Private Equity and Corporate Accounting Division at Goldman Sachs. From April 2011 to October 2012 he served as an Assistant Controller for Corporate Accounting and Financial Reporting at Safway Atlantic, a scaffolding and industrial services company. Prior to Safway Atlantic, Mr. Torres served as a Financial Analyst for PricewaterhouseCoopers from June 2007 to April 2011.Mr. Torres holds a bachelor's degree in Economics from Syracuse University.- 我们的首席财务官 Nicholas Torres III在金融和资本市场相关职位拥有超过15年的工作经验。自2021年12月以来，Torres先生一直担任Ascendex的高级财务总监，Ascendex是一家为全球用户提供各种产品的全球数字资产交易平台。2016年5月至2021年12月，他担任Bloomberg LP首席财务官服务部的财务总监。2012年11月至2016年4月，Torres先生担任高盛私募股权和企业会计部门的助理。2011年4月至2012年10月，他在脚手架和工业服务公司Safway Atlantic担任公司会计和财务报告助理总监。在加入Safway Atlantic之前，Torres先生于2007年6月至2011年4月担任普华永道的金融分析师。Torres先生拥有雪城大学的经济学学士学位。
- Nicholas Torres III,our Chief Financial Officer, has over 15 years of experience working in finance and capital markets-related roles. Since December 2021 Mr. Torres has been serving as the Senior Financial Controller for AscendEX, a global digital asset trading platform that offers a variety of products to global users. From May 2016 to December 2021 he served as a Controller in the Finance Division of CFO Services at Bloomberg LP. From November 2012 to April 2016 Mr. Torres served as an Associate for the Private Equity and Corporate Accounting Division at Goldman Sachs. From April 2011 to October 2012 he served as an Assistant Controller for Corporate Accounting and Financial Reporting at Safway Atlantic, a scaffolding and industrial services company. Prior to Safway Atlantic, Mr. Torres served as a Financial Analyst for PricewaterhouseCoopers from June 2007 to April 2011.Mr. Torres holds a bachelor's degree in Economics from Syracuse University.